from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0870c/-

LFCtreatmentdescriptionclass of inhibitor

-1.033

Amikacinug/mL Amikacintranslation

-0.306

Cap5-10ug/mL Capreomycintranslation

1.920

Rox10-50 ug/mL Roxithromycintranslation

-0.721

SM2-5 ug/mL Streptomycintranslation

-0.401

Tet5-10 ug/mL Tetracyclinetranslation

-0.843

Rif0.2-5ug/mL Rifampicintranscription

-1.262

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.961

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.585

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.475

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.150

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.398

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.232

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.768

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.087

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.482

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.333

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.622

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.155

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.604

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.639

KCN5-20 ug/mL Potassium cyaniderespiration

-0.807

NaN30.2-2 mM Sodium aziderespiration

-0.883

Nigericin50 uM Nigericinrespiration

0.489

TRC10-150 ug/mL Triclosanrespiration

-0.038

TRZ10-25 ug/mL Thioridazinerespiration

-0.043

Valinomycin0.5-10 uM Valinomycinrespiration

-1.482

ZnSO42 mM ZnSO4respiration

0.570

menadione6-10 ug/mL Menadionerespiration

-0.096

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.561

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.470

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.623

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.182

NRP_1Non-replicating persistence stage 1dosRassociated

-0.341

Amp0.2mg/mL AmpicillincellWall

-0.114

Cephalexin20-100 ug/mL CephalexincellWall

-0.633

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.680

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.596

EMB10-20 ug/mL EthambutolcellWall

-0.189

Eta12-40 ug/mL EthionamidecellWall

-0.098

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.280

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.226

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.801

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.878

BZA0.12 mg/mL BenzamidearomaticAmides

1.140

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.222

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.887

H2O24 mM hydrogen peroxideDNAdamaging

0.170

Levo10 ug/mL LevofloxacinDNAdamaging

-0.058

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.359

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.453

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.345

UVUV-irradiationDNAdamaging

1.160

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.635

Antimycin12.5-50 ug/mL Antimycin A?

-1.072

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.598

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.618

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.309

PA8240.2-2 ug/mL PA-824?

1.337

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.389

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.608

Verapamil50 uM Verapamil?

-1.082

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.201

methoxatin10-20 ug/mL Methoxatin?